Access a multi-indication oncology dataset based on EMR data that offers comprehensive insights into the full range of oncological diseases, revealing unmet epidemiological needs and providing a holistic understanding of patient journeys at scale.
Vista allows life sciences to holistically track the journeys of real oncology patients across the disease spectrum. The inclusion of non-oncological data enables further identification of epidemiological trends and guidance of research decisions.
Vista uses structured EMR data and machine learning to standardize patient data across disease states and treatment protocols for easy comparative analysis.
Vista is continuously being improved and enriched with data and clinical logic through collaboration with biopharma partners.
Real-World Insights and Support is an optional add-on that pairs perfectly with your Vista data. Our team of clinical experts, researchers, and statisticians will come alongside your teams to help them use the data to design studies, run analyses, and construct regulatory submission packages.
Explore our collection of clinical research, recent press, podcasts, and more.
NEW YORK–(BUSINESS WIRE)–COTA Inc., a leader in real-world data (RWD) and analytics for oncology, announces a new partnership with leading...
Findings to be Presented at the San Antonio Breast Cancer Symposium NEW YORK, Dec. 9, 2024 /PRNewswire/ — COTA Inc.,...
For over a decade, COTA has been tackling the most complicated cancer data to produce real-world data that can power...
Discover the power of real-world cancer data to help you understand patient journeys across the oncology spectrum and inform research directions.
